deferoxamine has been researched along with Lymphoma, Non-Hodgkin in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franchini, M | 1 |
| Gandini, G | 1 |
| Veneri, D | 1 |
| Aprili, G | 1 |
| Voest, EE | 1 |
| Neijt, JP | 1 |
| Keunen, JE | 1 |
| Dekker, AW | 1 |
| van Asbeck, BS | 1 |
| Nortier, JW | 1 |
| Ros, FE | 1 |
| Marx, JJ | 1 |
1 trial available for deferoxamine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Do | 1993 |
1 other study available for deferoxamine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload: an update.
Topics: Aged; Anemia; Deferoxamine; Female; Humans; Injections, Subcutaneous; Iron Chelating Agents; Iron Ov | 2004 |